Inflammatory response to trauma: Implications for coagulation and resuscitation

Current Opinion in Anaesthesiology

Volumn 27, Issue 2, 2014, Pages 246-252

  Pierce, Albert ^a   Pittet, Jean François ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

acute traumatic coagulopathy; fluid resuscitation; immunosuppression; inflammatory response; resolution of inflammation

Indexed keywords

ANTIINFLAMMATORY ACTIVITY; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; FLUID RESUSCITATION; GLYCOCALYX; HUMAN; INFLAMMATION; INJURY; INNATE IMMUNITY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; REVIEW; BLOOD COAGULATION DISORDERS; COMPLICATION; RESUSCITATION; WOUNDS AND INJURIES;

BLOOD COAGULATION DISORDERS; HUMANS; INFLAMMATION; RESUSCITATION; WOUNDS AND INJURIES;

EID: 84896392490     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000047     Document Type: Review

References (87)

1. WISQARS database [Internet].
2. WHO. Injury and violence: the facts: WHO, Geneva Switzerland. Geneva Switzerland: WHO; 2010.
3. Desai KH, Tan CS, Leek JT, et al. Dissecting inflammatory complications in critically injured patients by within-patient gene expression changes: a longitudinal clinical genomics study. PLoS Med 2011; 8:e1001093.
4. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54:1127-1130. (Pubitemid 36764882)
5. Goris RJ, Te Boekhorst TP, Nuytinck JK, Gimbrere JS. Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg1985; 120:1109-1115. (Pubitemid 16229682)
6. Nuytinck HK, Offermans XJ, Kubat K, Goris JA. Whole-body inflammation in trauma patients. An autopsy study. Arch Surg 1988; 123:1519-1524.
7. Manson J, Thiemermann C, Brohi K. Trauma alarmins as activators of damageinduced inflammation. Br J Surg 2012; 99 (Suppl 1):12-20.
8. Marik PE, Flemmer M. The immune response to surgery and trauma: implications for treatment. J Trauma Acute Care Surg 2012; 73:801-808.
9. Peng Z, Pati S, Potter D, et al. Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock 2013; 40:195-202.
10. Cotton BA, Guy JS, Morris JA Jr, Abumrad NN. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006; 26:115-121. (Pubitemid 44162495)
11. del Junco DJ, Holcomb JB, Fox EE, et al. Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg 2013; 75 (1 Suppl 1):S24-S30.
12. Duchesne JC, Heaney J, Guidry C, et al. Diluting the benefits of hemostatic resuscitation: a multiinstitutional analysis. J Trauma Acute Care Surg 2013; 75:76-82.
13. Park PK, Cannon JW, Ye W, et al. Transfusion strategies and development of acute respiratory distress syndrome in combat casualty care. J Trauma Acute Care Surg 2013; 75 (2 Suppl 2):S238-S246.
14. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011; 208:2581-2590.
15. Chow CC, Clermont G, Kumar R, et al. The acute inflammatory response in diverse shock states. Shock 2005; 24:74-84. (Pubitemid 40946598)
16. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury 2007; 38:1336-1345. (Pubitemid 350192404)
17. Tsukamoto T, Chanthaphavong RS, Pape HC. Current theories on the pathophysiology of multiple organ failure after trauma. Injury 2010; 41:21-26.
18. Moore FA, Moore EE, Poggetti R, et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 1991; 31:629-636; discussion 36-8.
19. Deitch EA, Morrison J, Berg R, Specian RD. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit Care Med 1990; 18:529-536. (Pubitemid 20164878)
20. Magnotti LJ, Upperman JS, Xu DZ, et al. Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 1998; 228:518-527. (Pubitemid 30194395)
21. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296:301-305. (Pubitemid 34303674)
22. Jawa RS, Anillo S, Huntoon K, et al. Interleukin-6 in surgery, trauma, and critical care part II: clinical implications. J Intensive Care Med 2011; 26:73-87.
23. Gebhard F, Pfetsch H, Steinbach G, et al. Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg 2000; 135:291-295. (Pubitemid 30154569)
24. Faist E, Kupper TS, Baker CC, et al. Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg 1986; 121:1000-1005. (Pubitemid 16054185)
25. O'Mahony JB, Palder SB, Wood JJ, et al. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 1984; 24:869-875. (Pubitemid 15183653)
26. Keane RM, Birmingham W, Shatney CM, et al. Prediction of sepsis in the multitraumatic patient by assays of lymphocyte responsiveness. Surg Gynecol Obstet 1983; 156:163-167. (Pubitemid 13188512)
27. Livingston DH, Appel SH, Wellhausen SR, et al. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988; 123:1309-1312. (Pubitemid 18262709)
28. Szabo G, Kodys K, Miller-Graziano CL. Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of Fc gamma RI cross-linking stimulation. J Clin Immunol 1991; 11:326-335.
29. Faist E, Schinkel C, Zimmer S, et al. Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma 1993; 34:846-853; discussion 53-4.
30. Lyons A, Kelly JL, Rodrick ML, et al. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 1997; 226:450-458; discussion 8-60.
31. MacConmara MP, Maung AA, Fujimi S, et al. Increased CD4\+CD25\+T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 2006; 244:514-523.
32. Harris HE, Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 2006; 7:774-778. (Pubitemid 44275393)
33. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464:104-107.
34. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005; 17:359-365. (Pubitemid 40848537)
35. Krysko DV, Agostinis P, Krysko O, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011; 32:157-164.
36. Huang H, Evankovich J, Yan W, et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011; 54:999-1008.
37. Janeway CA Jr, Medzhitov R. Innate immune recognition. Ann Rev Immunol 2002; 20:197-216. (Pubitemid 34293424)
38. Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012; 72:1491-1501.
39. Gando S, Kameue T, Matsuda N, et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost 2002; 88:943-949. (Pubitemid 36018780)
40. Serhan CN, Brain SD, Buckley CD, et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007; 21:325-332. (Pubitemid 46213480)
41. Recchiuti A, Serhan CN. Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation. Front Immunol 2012; 3:298.
42. Peden M, McGee K, Sharma G. The injury chart book: a graphical overview of the burden of injuries. Geneva, Switzerland: WHO; 2002.
43. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006; 60 (6 Suppl):S3-S11.
44. Esmon CT, Xu J, Lupu F. Innate immunity and coagulation. J Thromb Haemost 2011; 9 (Suppl 1):182-188.
45. Semeraro F, Ammollo CT, Morrissey JH, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011; 118:1952-1961.
46. Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood 2009; 114:2367-2374.
47. Xu J, Zhang X, Monestier M, et al. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 2011; 187:2626-2631.
48. Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004; 109:2698-2704. (Pubitemid 38737913)
49. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM. The plateletactivating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 2002; 30 (5 Suppl):S294-S301. (Pubitemid 34508006)
50. Degen JL, Bugge TH, Goguen JD. Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 2007; 5 (Suppl 1):24-31. (Pubitemid 46958813)
51. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532-1535. (Pubitemid 38314426)
52. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13:34-45. This review of thrombosis-mediated immune activation introduces the term thromboimmunity.
53. Christiaans SC, Wagener BM, Esmon CT, Pittet JF. Protein C and acute inflammation: a clinical and biological perspective. Am J Physiol Lung Cell Mol Physiol 2013; 305:L455-L466.
54. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245:812-818. (Pubitemid 46684113)
55. Chesebro BB, Rahn P, Carles M, et al. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock 2009; 32:659-665.
56. Kutcher ME, Xu J, Vilardi RF, et al. Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C. J Trauma Acute Care Surg 2012; 73:1389-1394.
57. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski S.R. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254:194-200.
58. Johansson PI, Windelov NA, Rasmussen LS, et al. Blood levels of histonecomplexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock 2013; 6:171-175.
59. Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009; 22:155-162.
60. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723-740.
61. Torres LN, Sondeen JL, Ji L, et al. Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow, and coagulation function after hemorrhagic shock in rats. J Trauma Acute Care Surg 2013; 75:759-766.
62. Mulivor AW, Lipowsky HH. Inflammation-and ischemia-induced shedding of venular glycocalyx.AmJ Physiol Heart Circ Physiol 2004;286:H1672-H1680. (Pubitemid 38525453)
63. Cohen MJ. Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation. Surg Clin North Am 2012; 92:877-891; viii.
64. Neher MD, Weckbach S, Flierl MA, et al. Molecular mechanisms of inflammation and tissue injury after major trauma: is complement the 'bad guy'? J Biomed Sci 2011; 18:90.
65. Bruegger D, Jacob M, Rehm M, et al. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol 2005; 289:H1993-H1999. (Pubitemid 41507349)
66. Mulivor AW, Lipowsky HH. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol 2002; 283:H1282-H1291.
67. Stein DM, Scalea TM. Capillary leak syndrome in trauma: what is it and what are the consequences? Adv Surg 2012; 46:237-253.
68. Andersen LW, Mackenhauer J, Roberts JC, et al. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc 2013; 88:1127-1140.
69. Rixen D, Raum M, Holzgraefe B, et al. A pig hemorrhagic shock model: oxygen debt and metabolic acidemia as indicators of severity. Shock 2001; 16:239-244. (Pubitemid 33598204)
70. Dutton RP. Resuscitative strategies to maintain homeostasis during damage control surgery. Br J Surg 2012; 99 (Suppl 1):21-28.
71. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care, AANS/CNS. Bratton SL, Chestnut RM, Ghajar J. Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation. J Neurotrauma 2007; 24 (Suppl 1):S7-S13.
72. Brown JB, Cohen MJ, Minei JP, et al. Goal-directed resuscitation in the prehospital setting: a propensity-adjusted analysis. J Trauma Acute Care Surg 2013; 74:1207-1212; discussion 12-4.
73. Hampton DA, Fabricant LJ, Differding J, et al. Prehospital intravenous fluid is associated with increased survival in trauma patients. J Trauma Acute Care Surg 2013; 75 (1 Suppl 1):S9-S15.
74. Ley EJ, Clond MA, Srour MK, et al. Emergency department crystalloid resuscitation of 1.5 l or more is associated with increased mortality in elderly and nonelderly trauma patients. J Trauma 2011; 70:398-400.
75. Frenzel T, Van Aken H, Westphal M. Our own blood is still the best thing to have in our veins. Curr Opin Anaesthesiol 2008; 21:657-663.
76. Engelbrecht S, Wood EM, Cole-Sinclair MF. Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards. Med J Australia 2013; 199:397-401.
77. Stramer SL. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007; 131:702-707. (Pubitemid 46729528)
78. Dodd RY. Current safety of the blood supply in the United States. Int J Hematol 2004; 80:301-305. (Pubitemid 39564628)
79. Jackman RP, Utter GH, Muench MO, et al. Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion 2012; 52:2533-2550.
80. Vlaar AP, Hofstra JJ, Determann RM, et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011; 117:4218-4225.
81. Burman S, Cotton BA. Trauma patients at risk for massive transfusion: the role of scoring systems and the impact of early identification on patient outcomes. Exp Rev Hematol 2012; 5:211-218.
82. Holcomb JB, Spinella PC. Optimal use of blood in trauma patients. Biologicals 2010; 38:72-77.
83. Khan S, Allard S, Weaver A, et al. A major haemorrhage protocol improves the delivery of blood component therapy and reduces waste in trauma massive transfusion. Injury 2013; 44:587-592.
84. Schochl H, Schlimp CJ. Trauma bleeding management: the concept of goaldirected primary care. Anesth Analg 2013. [Epub ahead of print]
85. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63:805-813. (Pubitemid 350287298)
86. Shaz BH, Dente CJ, Nicholas J, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010; 50:493-500.
87. Spinella PC, Perkins JG, Grathwohl KW, et al. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma 2008; 64 (2 Suppl):S69-S77; discussion S-8.